Biomarkers C12 Technical Information

Biochip technology is a novel parallel analytical approach. It combines micro-electronics, micro-mechanics, chemistry, physics and ICT and makes concatenation, integration and miniaturization of sample processing, signal detection and analysis possible.

Biomarkers C12 is based on protein chip biotechnology to detect protein interactions, binding of antigens to antibodies. Multiple antibodies are immobilized on a solid matrix, to capture specific tumor markers in serum samples. The concentrations of tumor markers are determined quantitatively through a chemiluminescent mechanism.

Biomarkers C12 for multi-tumor marker detection can be applied for rapid and accurate diagnosis of tumor and tumor screening in asymptomatic population. It is especially useful when use in conjunction with other diagnostic tools such as the 64-Slice MSCT, Ultrasound, Mammogram and PET-CT, etc.


Further reading for technical persons

(We select only articles we believe are useful and accurate. However as science is subject to rapid change, we cannot guarantee the standards of such articles. We will continually upgrade this page and we welcome suggestions from you.)



A Protein Chip System for Parallel Analysis of Multi-tumor Markers and its Application in Cancer Detection

Multi-marker protein panels for cancer diagnosis

Clinical Evaluation of Biomarkers C12

Sample Images of Biomarkers C12

Sample of Biomarkers C12 Report

Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer
from Benign Prostate Hyperplasia and Healthy Men

On the technicalities of discovering and applying protein biomarkers for cancer prevention

Protein chips could speed cancer detection

Early detection of ovarian cancer: A realistic approach ?